Cell and Gene Manufacturing and Logistics

1. Navigating Allogeneic Cell Therapy Supply Chain Management 6/11/2025

   In 2024, allogeneic cell therapies gained clinical momentum and regulatory attention, prompting increased collaboration between developers and the FDA to address safety, manufacturing, and access challenges critical to broader adoption and commercialization.

2. Fluid Management Made Simple With IRIS Single-Use Assemblies 6/11/2025

   Get your customized IRIS single-use assembly & tubing system based on different tubing modules and aseptic connectors directly from Single Use Support.

3. Navigating Data Management Requirements For Sterile Manufacturing 6/11/2025

   Contamination control strategies are rooted in representative and trustworthy data, but companies still do a poor job at maximizing their use of data to optimize.

4. Gibco Efficient-Pro Medium And Feeds Evaluation Guide 6/9/2025

   Discover a high-performing solution for mAb production designed to significantly improve titers, cell viability, and protein quality in CHO cell lines.

5. CTS Detachable Dynabeads CD3/CD28 Magnetic Beads 6/9/2025

   Move beyond the limitations of passive dissociation in your T-cell workflows. A next-generation solution enables active, on-demand release of magnetic beads from your target cells.

6. Comparing Serum-free To Serum-Supplemented Media 6/9/2025

   Reducing serum in vaccine manufacturing is a key consideration for lowering costs and improving supply security. We compare performance in serum-free versus serum-supplemented media.

7. A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications 6/9/2025

   Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

8. End-To-End Services In Contract Manufacturing 6/9/2025

   Discover how flexible, high-quality manufacturing solutions support biopharma innovation and help bring effective therapies to patients around the world.

9. Advantages Of Our Expertise In Proprietary Cell Lines 6/9/2025

   Explore how proprietary cell lines enhance development, reduce costs, and accelerate market entry with built-in regulatory support and extensive expertise in adherent cell culture.

10. Exploring The Challenges Of Cell Dissociation In Vaccine Manufacturing 6/9/2025

    Vaccine manufacturing relies on efficient cell dissociation methods. Explore the challenges of traditional approaches like trypsin and the benefits of animal origin-free alternatives for improved workflows.